 |
PDBsum entry 5eb2
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
5eb2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription
|
 |
|
Title:
|
 |
Trp-bound yfir
|
|
Structure:
|
 |
Yfir. Chain: a, b. Fragment: unp residues 35-190. Engineered: yes
|
|
Source:
|
 |
Pseudomonas aeruginosa pao1. Organism_taxid: 208964. Strain: pao1. Gene: yfir, pa1121. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.71Å
|
R-factor:
|
0.197
|
R-free:
|
0.230
|
|
|
Authors:
|
 |
M.Xu,X.Yang,X.-A.Yang,L.Zhou,T.-Z.Liu,Z.Fan,T.Jiang
|
|
Key ref:
|
 |
M.Xu
et al.
(2016).
Structural insights into the regulatory mechanism of the Pseudomonas aeruginosa YfiBNR system.
Protein Cell,
7,
403-416.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Oct-15
|
Release date:
|
18-May-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9I4L4
(Q9I4L4_PSEAE) -
Negative regulator YfiR from Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
190 a.a.
153 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Protein Cell
7:403-416
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insights into the regulatory mechanism of the Pseudomonas aeruginosa YfiBNR system.
|
|
M.Xu,
X.Yang,
X.A.Yang,
L.Zhou,
T.Z.Liu,
Z.Fan,
T.Jiang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
YfiBNR is a recently identified bis-(3'-5')-cyclic dimeric GMP (c-di-GMP)
signaling system in opportunistic pathogens. It is a key regulator of biofilm
formation, which is correlated with prolonged persistence of infection and
antibiotic drug resistance. In response to cell stress, YfiB in the outer
membrane can sequester the periplasmic protein YfiR, releasing its inhibition of
YfiN on the inner membrane and thus provoking the diguanylate cyclase activity
of YfiN to induce c-di-GMP production. However, the detailed regulatory
mechanism remains elusive. Here, we report the crystal structures of YfiB alone
and of an active mutant YfiB(L43P) complexed with YfiR with 2:2 stoichiometry.
Structural analyses revealed that in contrast to the compact conformation of the
dimeric YfiB alone, YfiB(L43P) adopts a stretched conformation allowing
activated YfiB to penetrate the peptidoglycan (PG) layer and access YfiR.
YfiB(L43P) shows a more compact PG-binding pocket and much higher PG binding
affinity than wild-type YfiB, suggesting a tight correlation between PG binding
and YfiB activation. In addition, our crystallographic analyses revealed that
YfiR binds Vitamin B6 (VB6) or L-Trp at a YfiB-binding site and that both VB6
and L-Trp are able to reduce YfiB(L43P)-induced biofilm formation. Based on the
structural and biochemical data, we propose an updated regulatory model of the
YfiBNR system.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |